Proactive Investors - Run By Investors For Investors

Kromek “will achieve cash breakeven this year”, says Cantor Fitzgerald

While the group's medical arm was the "key" growth driver, the broker said that the nuclear and security screening businesses would provide "immediately realisable" earnings
Nuclear detection
Cantor has Kromek rated at 'buy' with a 45p price target

Kromek Group PLC (LON:KMK) will achieve cash breakeven this year, according to analysts at Cantor Fitzgerald, who on Friday reiterated their ‘buy’ rating and 45p target price on the stock.

The broker said they expected revenue growth for the radiation detection specialist to continue in the “mid- to high-teens range”, adding that the group’s medical imaging arm was the “key medium-term driver” of growth.

READ: Kromek on a roll as it announces another three contract wins

Cantor also said that the company’s nuclear and security screening offerings would provide “more immediately realisable earnings and cash”.

Overall, the broker said Kromek was building “a strong customer, manufacturing and intellectual property base”, with cash breakeven the next milestone for the group.

In mid-afternoon trading, Kromek shares were 1% lower at 24.3p.

View full KMK profile View Profile

Kromek Group PLC Timeline

Related Articles

Irrigation
May 15 2019
The company’s products can be used for wireless and mobile internet applications, while its military hardware encompasses a range of tactical and specialised communications antennas
machines
July 04 2019
The company has so far in 2019 signed a number of deals for its technology, including an agreement for safety features in self-driving cars
Keywords Studio
June 17 2019
Keywords has a buy-and-build strategy and has been expanding rapidly since its first acquisition in 2014.
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use